缺血性卒中后LDL-C目标<70 mg/dL对颈动脉粥样硬化演变的影响
低目标组颈动脉新斑块发生率与高目标组相似,但颈总动脉内中膜厚度进展显著更少(组间差异-7.84 µm,P=0.004)。
要点
- LDL-C<70 mg/dL未减少颈动脉新斑块发生(5年率26.1% vs 29.7%)。
- 低目标组颈总动脉内中膜厚度变化为-10.53 µm,提示粥样硬化逆转。
- 组间内中膜厚度绝对差异-7.84 µm(95%CI -13.18至-2.51,P=0.004)。
核心结论
- 在动脉粥样硬化性缺血性卒中患者中,LDL-C目标<70 mg/dL未降低颈动脉新斑块发生率,但较90-110 mg/dL目标显著促进颈动脉粥样硬化逆转。
研究设计与样本
- TST-PLUS为TST试验的颈动脉超声子研究,纳入201例低目标组(LDL-C<70 mg/dL)和212例高目标组(100±10 mg/dL)。
- 超声检查在基线及2、3、5年进行,由中心核心实验室盲法测量颈总动脉内中膜厚度。
主要发现
- 中位随访3.1年,低目标组实际LDL-C为64 mg/dL(1.64 mmol/L),高目标组为106 mg/dL(2.72 mmol/L)。
- 新诊断颈动脉斑块:低目标组46/201(5年率26.1%),高目标组45/212(5年率29.7%)。
- 颈总动脉内中膜厚度变化:高目标组-2.69 µm(95%CI -6.55至1.18),低目标组-10.53 µm(95%CI -14.21至-6.85)。
- 组间绝对差异为-7.84 µm(95%CI -13.18至-2.51;P=0.004)。
关键数值与推荐
- 颈动脉斑块采用Mannheim共识定义。
- LDL-C目标分别为<70 mg/dL和100±10 mg/dL,降脂药物为他汀类联合或不联合依折麦布。
临床怎么用
- 对于动脉粥样硬化性缺血性卒中患者,强化降脂至LDL-C<70 mg/dL可延缓颈动脉粥样硬化进展。
- 颈动脉斑块新发风险未因更低LDL-C目标而显著降低,临床决策需综合评估。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The TST trial (Treat Stroke to Target) showed the benefit of targeting a low-density lipoprotein cholesterol (LDL-C) concentration of <70 mg/dL in terms of reducing the risk of major cardiovascular events in 2860 patients with ischemic stroke with atherosclerotic stenosis of cerebral vasculature. The impact on carotid atherosclerosis evolution is not known. METHODS: TST-PLUS (Treat Stroke to Target-Plaque Ultrasound Study) included 201 patients assigned to an LDL-C concentration of <70 mg/dL and 212 patients assigned to a target of 100±10 mg/dL. To achieve these goals, investigators used the statin and dosage of their choice and added ezetimibe as needed. Ultrasonographers were certified and carotid ultrasound examinations were performed using M'Ath software at baseline and at 2, 3, and 5 years. All images were uploaded to the Intelligence in Medical Technologies database directly from the carotid ultrasound device. The central core laboratory performed all offline measurements of the intima-media thickness of both common carotid arteries blinded from the randomization arm. The main outcomes were newly diagnosed atherosclerotic plaque on carotid bifurcation or internal carotid artery using the Mannheim consensus definition and between-group comparison of common carotid arteries intima-media thickness change. RESULTS: After a median follow-up of 3.1 years, the achieved LDL-C concentrations were 64 mg/dL (1.64 mmol/L) in the lower-target group and 106 mg/dL (2.72 mmol/L) in the higher-target group. Compared with the higher-target group, patients in the lower-target group had a similar incidence of newly diagnosed carotid plaque: 46/201 (5-year rate, 26.1%) versus 45/212 (5-year rate, 29.7%). The change in common carotid arteries intima-media thickness was -2.69 µm (95% CI, -6.55 to 1.18) in the higher-target group and -10.53 µm (95% CI, -14.21 to -6.85) in the lower-target group, resulting in an absolute between-group difference of -7.84 µm (95% CI, -13.18 to -2.51; P=0.004). CONCLUSIONS: In patients with ischemic stroke and atherosclerosis, an LDL-C target of <70 mg/dL (1.8 mmol/L) did not reduce the incidence of new carotid plaques but produced significantly greater regression of carotid atherosclerosis than an LDL-C target of 90 to 110 mg/dL. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01252875.
引用
- Amarenco P, Hobeanu C, Labreuche J, et al. Carotid Atherosclerosis Evolution When Targeting a Low-Density Lipoprotein Cholesterol Concentration <70 mg/dL After an Ischemic Stroke of Atherosclerotic Origin. Circulation. 2020. PMID: 32594766. doi:10.1161/CIRCULATIONAHA.120.046774
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。